https://news.augustaheadlines.com/story/530035/fgfr-inhibitor-market-set-for-robust-growth-through-2034-with-new-fda-clearances-expanding-indications-and-nextgen-therapies-delveinsight.html 2025-08-11T20:48:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/530034/fcrn-inhibitor-market-outlook-2034-fda-approvals-emerging-therapies-expanding-patient-pools-and-strong-commercial-uptake-delveinsight.html 2025-08-11T20:46:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/530032/arteriovenous-fistula-pipeline-insight-2025-endovascular-innovations-and-bioengineered-grafts-redefine-vascular-access-solutions-delveinsight.html 2025-08-11T20:44:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/530030/chronic-rhinosinusitis-pipeline-insight-2025-targeted-biologics-and-innovative-delivery-platforms-set-to-transform-care-delveinsight.html 2025-08-11T20:42:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/530028/chronic-periodontitis-pipeline-insight-2025-regenerative-therapies-and-hostmodulation-strategies-lead-the-next-wave-of-innovation-delveinsight.html 2025-08-11T20:38:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/530026/angioimmunoblastic-tcell-lymphoma-pipeline-insight-2025-targeted-immunotherapies-and-epigenetic-modulators-drive-nextgeneration-treatment-strategies-delveinsight.html 2025-08-11T20:36:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/530025/erosive-esophagitis-pipeline-insight-2025-advancing-beyond-acid-suppression-toward-mucosal-healing-and-relapse-prevention-delveinsight.html 2025-08-11T20:34:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/530023/acute-lymphocytic-leukemia-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-orca-biosystems-inc-jazz-pharmaceuticals-shenzhen-targetrx-inc-cellectis.html 2025-08-11T20:32:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/530021/dilated-cardiomyopathy-clinical-trials-companies-therapeutic-assessment-emerging-therapies-treatment-algorithm-and-pipeline-analysis-berlin-cures-astrazeneca-biohaven-pharmaceuticals-tenaya.html 2025-08-11T20:30:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/530020/chronic-spontaneous-urticaria-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-united-biopharma-teva-pharmaceuticals-development-inc-amgen-novartis-p.html 2025-08-11T20:28:03+00:00 daily 1.0